Teladoc Health (TDOC) Liabilities and Shareholders Equity (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $2.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 18.5% year-over-year to $2.8 billion; the trailing twelve-month figure through Mar 2026 stood at $11.4 billion (down 18.38% YoY), and the FY2025 full-year result was $2.9 billion, down 18.72% from the prior year.
• Liabilities and Shareholders Equity declined to $2.8 billion in Q1 2026, from $2.9 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $11.1 billion in Q1 2022 to a low of $2.8 billion in Q1 2026.
• A 5-year average of $4.6 billion and a median of $4.3 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 75.5% in 2022 and advanced 1.08% in 2023, its largest moves.
• Tracing TDOC's Liabilities and Shareholders Equity over 5 years: stood at $4.3 billion in 2022, then advanced by 1.08% to $4.4 billion in 2023, then declined by 19.94% to $3.5 billion in 2024, then decreased by 18.72% to $2.9 billion in 2025, then fell by 1.79% to $2.8 billion in 2026.
• Business Quant data shows TDOC's Liabilities and Shareholders Equity at $2.8 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.